Cargando…
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
The immune checkpoint blockade is an effective strategy to enhance the anti-tumor T cell effector activity, thus becoming one of the most promising immunotherapeutic strategies in the history of cancer treatment. Several immune checkpoint inhibitor have been approved by the FDA, such as anti-CTLA-4,...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797440/ https://www.ncbi.nlm.nih.gov/pubmed/33416134 http://dx.doi.org/10.3892/ijmm.2020.4817 |